{"id":842997,"date":"2026-10-21T16:37:02","date_gmt":"2026-10-21T16:37:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=842997"},"modified":"2026-10-21T16:37:02","modified_gmt":"2026-10-21T16:37:02","slug":"iontophoresis-electrode-pads-support-treatment-research-for-hyperhidrosis-management","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/iontophoresis-electrode-pads-support-treatment-research-for-hyperhidrosis-management_842997.html","title":{"rendered":"Iontophoresis Electrode Pads Support Treatment Research for Hyperhidrosis Management"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Shenzhen, China &#8211; October 21, 2026 &#8211;<\/strong>&nbsp;Hyperhidrosis is a common condition characterized by excessive sweating, affecting localized areas or the entire body. Among various physical and pharmacological interventions, iontophoresis treatment for hyperhidrosis has become a preferred first-line solution in both international clinical dermatology and home-care settings due to its non-invasive nature, high safety profile, and proven efficacy. This article provides an in-depth analysis of the mechanisms, suitable patient populations, and the critical role that high-quality iontophoresis electrode pads play in enhancing therapeutic outcomes.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/ecdn6.globalso.com\/upload\/p\/6438\/image_other\/2026-10\/image-1-7.png\" alt=\"\u56fe\u72471.png\" \/><\/p>\n<p style=\"text-align: justify;\">1. What is Iontophoresis Therapy and How Does It Work?<\/p>\n<p style=\"text-align: justify;\">Iontophoresis technology was first introduced for hyperhidrosis treatment in 1936. The procedure utilizes a specialized device to pass a mild, safe electrical current through the skin in affected areas, thereby suppressing excessive sweat production.<\/p>\n<p style=\"text-align: justify;\">Current medical literature explains the therapeutic mechanism through three main physiological theories:<\/p>\n<p style=\"text-align: justify;\">\u25cf Blocking Sweat Output: The combination of electrical current and mineral particles in water temporarily plugs the sweat gland ducts at the skin&#8217;s surface.<\/p>\n<p style=\"text-align: justify;\">\u25cf Disrupting Nerve Signals: The micro-current modulates localized autonomic nerve signal transmission, interrupting the impulses that trigger sweat glands.<\/p>\n<p style=\"text-align: justify;\">\u25cf pH Level Regulation: By altering the internal pH of sweat glands to make them more acidic, the overall volume of sweat production is reduced.<\/p>\n<p style=\"text-align: justify;\">Clinical data shows that following an initial recommended course, up to 85% of patients with palmar and plantar (hands and feet) hyperhidrosis experience significant relief, while success rates for axillary (underarm) and facial hyperhidrosis reach approximately 70%.<\/p>\n<p style=\"text-align: justify;\">2. Treatment Process and Pharmacological Adjuncts<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/ecdn6.globalso.com\/upload\/p\/6438\/image_other\/2026-10\/image-2-5.png\" alt=\"\u56fe\u72472.png\" \/><\/p>\n<p style=\"text-align: justify;\">Standard tap water iontophoresis therapy uses ordinary tap water as the conductive medium. However, in specialized dermatology clinics and NHS medical centers, clinicians may add a prescription solution known as glycopyrronium iontophoresis liquid (Glycopyrronium Solution) to the water trays or pads. This targeted anticholinergic drug further suppresses sweat secretion with minimal systemic side effects.<\/p>\n<p style=\"text-align: justify;\">\u25cf Treatment Schedule: The initial phase typically consists of 20&ndash;30 minute sessions, 2 to 3 times per week, over a period of 3 to 4 weeks.<\/p>\n<p style=\"text-align: justify;\">\u25cf Maintenance Regimen: Because iontophoresis is a control method rather than a permanent cure, patients transition to weekly or monthly maintenance sessions once initial symptom relief is achieved.<\/p>\n<p style=\"text-align: justify;\">\u25cf Patient Experience: Patients may experience a mild tingling or itching sensation during treatment, which is well-tolerated by most adults and children over 5 years old.<\/p>\n<p style=\"text-align: justify;\">3. Contraindications and Safety Guidelines<\/p>\n<p style=\"text-align: justify;\">Although iontophoresis is exceptionally safe, strict adherence to safety guidelines is essential:<\/p>\n<p style=\"text-align: justify;\">\u25cf Cardiac Pacemakers: Individuals with implanted pacemakers or ICDs must avoid iontophoresis therapy.<\/p>\n<p style=\"text-align: justify;\">\u25cf Metal Implants: Caution is advised if metal implants (such as artificial joints) lie directly within the electrical current pathway.<\/p>\n<p style=\"text-align: justify;\">\u25cf Special Populations: Iontophoresis is generally not recommended during pregnancy due to limited risk data, but it is considered safe during breastfeeding. Treatment for children under 12 requires physician consultation.<\/p>\n<p style=\"text-align: justify;\">\u25cf Pre-treatment Steps: All jewelry must be removed prior to treatment, and open wounds or skin lesions should be protected or avoided.<\/p>\n<p style=\"text-align: justify;\">4. CMAI Medical: High-Performance Medical Iontophoresis Electrodes &amp; Solutions<\/p>\n<p style=\"text-align: justify;\">The ultimate success of iontophoresis treatment depends not only on current parameters but also on uniform current distribution and optimal skin conformity. While traditional water tray methods are geographically limited, utilizing high-conductivity, flexible iontophoresis electrode pads dramatically improves the treatment experience for complex anatomical areas such as the underarms, back, groin, and face.<\/p>\n<p style=\"text-align: justify;\">As a professional manufacturer of medical electrode components, CMAI specializes in delivering high-performance home iontophoresis device accessories and custom hyperhidrosis electrode pad OEM services for global medical equipment brands:<\/p>\n<p style=\"text-align: justify;\">\u25cf Uniform Current Distribution &amp; Protection: Utilizing premium Ag\/AgCl (silver\/silver chloride) conductive layers and conductive hydrogels to ensure even current delivery, eliminating local hotspots that cause burns or blisters.<\/p>\n<p style=\"text-align: justify;\">\u25cf Multi-Scenario Adaptability: Offering versatile flexible electrode pads and non-woven\/sponge pad integrations tailored for hands, feet, underarms, and facial contours.<\/p>\n<p style=\"text-align: justify;\">\u25cf ISO 13485 Certification: Manufactured under stringent medical quality control systems, complying with EU MDR and global regulatory standards.<\/p>\n<p style=\"text-align: justify;\">5. Contact CMAI Technology Co., Ltd<\/p>\n<p style=\"text-align: justify;\">To learn more about iontophoresis technology advancements, sourcing medical iontophoresis electrodes, or requesting free product samples, please visit CMAI Technology Co., Ltd at www.cmaimed.com or contact our medical engineering team directly.<\/p>\n<p style=\"text-align: justify;\"><strong>About us<\/strong><\/p>\n<p style=\"text-align: justify;\">CMAI Technology Co., Ltd. focuses on the R&amp;D, production, sales, and service of advanced medical consumable electrode pads.Headquartered in Shenzhen, China, we provide reliable high-performance electrode solutions for physiotherapy, rehabilitation, elderly care, and medical monitoring applications worldwide.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/cmaisz.com_176491.html\" rel=\"nofollow\">CMAI International Co., Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Media Relations<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=iontophoresis-electrode-pads-support-treatment-research-for-hyperhidrosis-management\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Country:<\/strong> China<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.cmaisz.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.cmaisz.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=iontophoresis-electrode-pads-support-treatment-research-for-hyperhidrosis-management\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shenzhen, China &#8211; October 21, 2026 &#8211;&nbsp;Hyperhidrosis is a common condition characterized by excessive sweating, affecting localized areas or the entire body. Among various physical and pharmacological interventions, iontophoresis treatment for hyperhidrosis has become a preferred first-line solution in both &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/iontophoresis-electrode-pads-support-treatment-research-for-hyperhidrosis-management_842997.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,410,403,404,416],"tags":[],"class_list":["post-842997","post","type-post","status-publish","format-standard","hentry","category-Business","category-Manufacturing-Industry","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/842997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=842997"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/842997\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=842997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=842997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=842997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}